BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

379 related articles for article (PubMed ID: 29762257)

  • 1. Evaluation of Safety Guidelines on the Use of Iodinated Contrast Material: Conundrum Continued.
    Nijssen EC; Nelemans PJ; Rennenberg RJ; van Ommen V; Wildberger JE
    Invest Radiol; 2018 Oct; 53(10):616-622. PubMed ID: 29762257
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Prophylactic hydration to protect renal function from intravascular iodinated contrast material in patients at high risk of contrast-induced nephropathy (AMACING): a prospective, randomised, phase 3, controlled, open-label, non-inferiority trial].
    Nijssen EC; Rennenberg RJ; Nelemans PJ; Essers BA; Janssen MM; Vermeeren MA; van Ommen V; Wildberger JE
    Ned Tijdschr Geneeskd; 2018; 161():D1734. PubMed ID: 29328007
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prophylactic hydration to protect renal function from intravascular iodinated contrast material in patients at high risk of contrast-induced nephropathy (AMACING): a prospective, randomised, phase 3, controlled, open-label, non-inferiority trial.
    Nijssen EC; Rennenberg RJ; Nelemans PJ; Essers BA; Janssen MM; Vermeeren MA; Ommen VV; Wildberger JE
    Lancet; 2017 Apr; 389(10076):1312-1322. PubMed ID: 28233565
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact on clinical practice of updated guidelines on iodinated contrast material: CINART.
    Nijssen EC; Nelemans PJ; Rennenberg RJ; van der Molen AJ; van Ommen GV; Wildberger JE
    Eur Radiol; 2020 Jul; 30(7):4005-4013. PubMed ID: 32107605
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prophylaxis in High-Risk Patients With eGFR < 30 mL/min/1.73 m2: Get the Balance Right.
    Nijssen EC; Nelemans PJ; Rennenberg RJ; Theunissen RA; van Ommen V; Wildberger JE
    Invest Radiol; 2019 Sep; 54(9):580-588. PubMed ID: 31033672
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prophylactic Intravenous Hydration to Protect Renal Function From Intravascular Iodinated Contrast Material (AMACING): Long-term Results of a Prospective, Randomised, Controlled Trial.
    Nijssen EC; Nelemans PJ; Rennenberg RJ; van Ommen V; Wildberger JE
    EClinicalMedicine; 2018; 4-5():109-116. PubMed ID: 31193613
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Meta-analysis of prophylactic hydration versus no hydration on contrast-induced acute kidney injury.
    Jiang Y; Chen M; Zhang Y; Zhang N; Yang H; Yao J; Zhou Y
    Coron Artery Dis; 2017 Dec; 28(8):649-657. PubMed ID: 28692484
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Hydration to prevent contrast-induced nephropathy].
    Hoorn EJ; Zietse R
    Ned Tijdschr Geneeskd; 2018; 161():D2442. PubMed ID: 29328017
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Influence of Clinical Factors on Risk of Contrast-Induced Nephrotoxicity From IV Iodinated Low-Osmolality Contrast Material in Patients With a Low Estimated Glomerular Filtration Rate.
    Ellis JH; Khalatbari S; Yosef M; Cohan RH; Davenport MS
    AJR Am J Roentgenol; 2019 Nov; 213(5):W188-W193. PubMed ID: 31268731
    [No Abstract]   [Full Text] [Related]  

  • 10. Prophylactic hydration to protect renal function from intravascular iodinated contrast material.
    Baheti AD; Jankharia B
    Natl Med J India; 2017; 30(5):272-273. PubMed ID: 29916428
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Epidemiology of contrast material-induced nephropathy in the era of hydration.
    Balemans CE; Reichert LJ; van Schelven BI; van den Brand JA; Wetzels JF
    Radiology; 2012 Jun; 263(3):706-13. PubMed ID: 22535561
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of intravenous hydration in preventing post-contrast acute kidney injury in patients with eGFR < 30 mL/min/1.73 m
    Yan P; Duan SB; Luo XQ; Zhang NY; Deng YH
    Eur Radiol; 2023 Dec; 33(12):9434-9443. PubMed ID: 37368109
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The lack of benefit of a combination of an angiotensin receptor blocker and calcium channel blocker on contrast-induced nephropathy in patients with chronic kidney disease.
    Oguzhan N; Cilan H; Sipahioglu M; Unal A; Kocyigit I; Kavuncuoglu F; Arikan T; Akpek M; Elcik D; Sahin O; Gulme E; Pala C; Tokgoz B; Utas C; Oguzhan A; Oymak O
    Ren Fail; 2013; 35(4):434-9. PubMed ID: 23413781
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intravenous N-acetylcysteine plus high-dose hydration versus high-dose hydration and standard hydration for the prevention of contrast-induced nephropathy: CASIS--a multicenter prospective controlled trial.
    Koc F; Ozdemir K; Kaya MG; Dogdu O; Vatankulu MA; Ayhan S; Erkorkmaz U; Sonmez O; Aygul MU; Kalay N; Kayrak M; Karabag T; Alihanoglu Y; Gunebakmaz O
    Int J Cardiol; 2012 Mar; 155(3):418-23. PubMed ID: 21106264
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hydration with sodium bicarbonate does not prevent contrast nephropathy: a multicenter clinical trial.
    Gomes VO; Lasevitch R; Lima VC; Brito FS; Perez-Alva JC; Moulin B; Arruda A; Oliveira D; Caramori P
    Arq Bras Cardiol; 2012 Dec; 99(6):1129-34. PubMed ID: 23184077
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Post-Contrast Acute Kidney Injury and Intravenous Prophylactic Hydration: An Update.
    Nijssen EC; Rennenberg R; Nelemans P; van Ommen V; Wildberger JE
    Rofo; 2021 Feb; 193(2):151-159. PubMed ID: 33327033
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dosing of iodinated contrast volume: a new simple algorithm to stratify the risk of contrast-induced nephropathy in patients with acute coronary syndrome.
    Raposeiras-Roubín S; Abu-Assi E; Ocaranza-Sánchez R; Alvarez-Álvarez B; Cambeiro-González C; Fandiño-Vaquero R; García-Castelo A; García-Acuña JM; González-Juanatey JR
    Catheter Cardiovasc Interv; 2013 Nov; 82(6):888-97. PubMed ID: 23362013
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy of nicorandil treatment for prevention of contrast-induced nephropathy in high-risk patients undergoing cardiac catheterization: A prospective randomized controlled trial.
    Iranirad L; Hejazi SF; Sadeghi MS; Jang SA
    Cardiol J; 2017; 24(5):502-507. PubMed ID: 28281738
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prevention of contrast nephropathy by furosemide with matched hydration: the MYTHOS (Induced Diuresis With Matched Hydration Compared to Standard Hydration for Contrast Induced Nephropathy Prevention) trial.
    Marenzi G; Ferrari C; Marana I; Assanelli E; De Metrio M; Teruzzi G; Veglia F; Fabbiocchi F; Montorsi P; Bartorelli AL
    JACC Cardiovasc Interv; 2012 Jan; 5(1):90-7. PubMed ID: 22230154
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effectiveness of theophylline in preventing contrast-induced nephropathy after coronary angiographic procedures.
    Bilasy ME; Oraby MA; Ismail HM; Maklady FA
    J Interv Cardiol; 2012 Aug; 25(4):404-10. PubMed ID: 22612071
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.